Experts Discuss the Evolution of CAR T-Cell Therapy in Multiple Myeloma

Experts Discuss the Evolution of CAR T-Cell Therapy in Multiple Myeloma is organized by Clinical Care Options (CCO), LLC.,Released: August 05, 2022,Expiration: August 04, 2023,Goal:,The goal of this program is to improve the knowledge and competence of learners in integrating CAR T-cell therapy into treatment plans for patients with hematologic malignancies.,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Discover the similarities and differences among currently available and emerging CAR T-cell therapies in multiple myeloma,• Identify patients who are likely to benefit from CAR T-cell therapy or are eligible for clinical trial enrollment,• Integrate into practice clinical trial data on CAR T-cell–based therapies for the treatment of multiple myeloma,• Manage toxicities associated with CAR T-cell therapy using available guidelines and online clinical resources and tools and implement strategies to educate patients eligible for this treatment about the potential for these complications,Additional details will be posted as soon as information is available.